{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-004747","form_type":"8-K","ticker":"PMDI","cik":"0000806517","company_name":"PSYCHEMEDICS CORP","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.938194+00:00","generated_at":"2026-05-31T09:54:44.303653+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Psychemedics Q2 revenue down 15% to $4.7M; net loss widens to $0.14/sh","bullets":["Q2 2024 revenue $4.7M vs $5.5M YoY (-15%); net loss $0.8M ($0.14/sh) vs $0.7M ($0.13/sh).","H1 2024 revenue $10.1M vs $11.4M YoY (-12%); net loss $1.5M ($0.26/sh) vs $1.1M ($0.19/sh).","CEO cites continued lower client hiring as primary driver of revenue decline.","Company adjusting operating costs while seeking new markets and applications."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-004747","json":"https://secwatch.observer/filing/0001171843-24-004747.json","markdown":"https://secwatch.observer/filing/0001171843-24-004747.md","text":"https://secwatch.observer/filing/0001171843-24-004747.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/806517/000117184324004747/0001171843-24-004747-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/806517/000117184324004747/f8k_081324.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:54:44.303653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}